Microbix Biosystems (TSE:MBX) Share Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX – Get Free Report) passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$0.28 and traded as low as C$0.27. Microbix Biosystems shares last traded at C$0.28, with a volume of 116,771 shares.

Microbix Biosystems Trading Down 6.8%

The firm has a fifty day simple moving average of C$0.30 and a 200-day simple moving average of C$0.28. The firm has a market cap of C$37.67 million, a P/E ratio of -7.64 and a beta of 0.41. The company has a debt-to-equity ratio of 27.69, a current ratio of 6.89 and a quick ratio of 5.57.

About Microbix Biosystems

(Get Free Report)

Microbix Biosystems Inc. creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.

Recommended Stories

Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.